Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Pharmacogenetics and Genomics|October 31, 2013
Pharmacogenetic-guided selection of warfarin versus novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: a cost-effectiveness analysisJoyce H S YouJournal of General Internal Medicine|October 18, 2013
Novel oral anticoagulants versus warfarin therapy at various levels of anticoagulation control in atrial fibrillation--a cost-effectiveness analysisJoyce H S YouPharmacogenomics|August 1, 2015
Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysisJoyce H S YouPathogens and Global Health|December 15, 2020
Impact of COVID-19 infection control measures on influenza-related outcomes in Hong KongJoyce H S YouCardiovascular Drugs and Therapy|December 8, 2016
CYP2C19 LOF and GOF-Guided Antiplatelet Therapy in Patients with Acute Coronary Syndrome: A Cost-Effectiveness AnalysisMinghuan Jiang, Joyce H S YouExpert Opinion on Pharmacotherapy|February 10, 2015
Review of pharmacoeconomic evaluation of genotype-guided antiplatelet therapyMinghuan Jiang, Joyce H S YouPlos One|October 7, 2024
Deprescribing of proton pump inhibitors in older patients: A cost-effectiveness analysisMingxi Xie, Joyce H S YouClinical Cardiology|July 7, 2017
Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndromeMinghuan Jiang, Joyce H S YouPharmacogenetics and Genomics|September 24, 2015
CYP2C19 genotype plus platelet reactivity-guided antiplatelet therapy in acute coronary syndrome patients: a decision analysisMinghuan Jiang, Joyce H S YouPlos One|December 15, 2022
Cost-effectiveness analysis of carbetocin for prevention of postpartum hemorrhage in a low-burden high-resource city of ChinaJoyce H S You, Tak-Yeung LeungPageof 8